Primary Myelofibrosis Completed Phase Trials for Palifermin (DB00039)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233921Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerSupportive Care